The Phase III clinical study results of Bio-Thera BAT2206 (a biosimilar developed based on ustekinumab) were published in the Journal of the American Academy of Dermatology [Google translation]

BAT2206 (ustekinumab biosimilar) - Bio-Thera Solutions, Pharmapark, Hikma, Biomm, Gedeon Richter, Astra Industrial Group

https://bio-thera.com/plus/view.php?aid=1133

Feb 20, 2025